Biogen Total Current Assets increased by 2.4% to $9.19B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.5%, from $7.63B to $9.19B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows an upward trend with a 5.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate stronger short-term liquidity, though excessive levels may suggest inefficient capital allocation.
The sum of all assets that are expected to be converted into cash or consumed within one year. This provides a snapshot...
Compared against current liabilities to determine the current ratio, a standard measure of short-term financial health.
total_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.18B | $7.16B | $7.86B | $7.92B | $9.74B | $9.77B | $9.79B | $9.76B | $10.43B | $8.45B | $6.86B | $6.76B | $7.11B | $6.83B | $7.46B | $7.63B | $7.97B | $8.94B | $8.97B | $9.19B |
| QoQ Change | — | -0.3% | +9.7% | +0.8% | +23.1% | +0.3% | +0.3% | -0.3% | +6.9% | -19.0% | -18.9% | -1.5% | +5.2% | -3.9% | +9.2% | +2.3% | +4.5% | +12.2% | +0.4% | +2.4% |
| YoY Change | — | — | — | — | +35.6% | +36.4% | +24.6% | +23.3% | +7.1% | -13.4% | -29.9% | -30.8% | -31.9% | -19.2% | +8.7% | +12.9% | +12.1% | +30.8% | +20.3% | +20.5% |